Breathe Well Live Well
|
Asthma-COPD overlap syndrome prevalent in patients with asthma with no …
Healio Toni Kiljander, MD, a pulmonary diseases and allergology specialist at Terveystalo Hospital in Finland, and colleagues conducted a cross-sectional study of patients with asthma who had no previous diagnosis of COPD but had a smoking history of at least … |
View full post on asthma – Google News
 |
Are the Diagnostic Criteria for Asthma-COPD Overlap Syndrome Appropriate in Biomass Smoke-Induced chronic obstructive pulmonary disease?
Arch Bronconeumol. 2015 Mar 19;
Authors: Golpe R, Pérez de Llano L
PMID: 25799499 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
Monthly Prescribing Reference |
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in … GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD New Inhalers for Asthma, COPD Launched GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
|
Vectura Inks Asthma/COPD License Agreement with Janssen
Genetic Engineering & Biotechnology News Vectura, a respiratory product development company, has entered a license agreement with Janssen Biotech to exclusively develop anti-inflammatory therapies for the treatment of asthma/COPD. The collaboration will initially focus on the development of a … |
View full post on asthma – Google News
|
Declaring War on Severe Asthma-COPD Overlap Syndrome
PR Newswire (press release) FOLSOM, Calif., May 6, 2013 /PRNewswire-iReach/ — War has been declared on Severe Asthma-COPD Overlap Syndrome (ACOS). It's tied in with recognition of World Asthma Day May 7, 2013. The World Asthma Foundation (WAF) is leading the charge to … |
View full post on asthma – Google News
|
Simple diagnostic tool for asthma,COPD remains unknown: Survey
Indian Express Spirometry, a dignostic tool for asthma and chronic obstructive pulmonary disease (COPD) remains poorly utilised in clinical practice, with few people having … Lung Disease: Leading Health Concern in Ontario Often … Are your lungs in good shape? Free tests will determine lung function |
View full post on asthma – Google News
|
Biopharma raising $500K eyes competitive asthma/COPD drug market
MedCity News A biopharmaceutical startup developing a new treatment for asthma that targets the nitric oxide signaling system has raised $50000 of a planned $500000 fundraise, according to recently filed SEC documents. SAJE Pharma LLC's lead compound appears to … |
View full post on asthma – Google News
|
Growing Number of Americans with Asthma/COPD to Drive Innovative Therapeutics …
Newswire Today (press release) In 2009, 40.3 million Americans were diagnosed with asthma or chronic obstructive pulmonary disease (COPD). Of these, 25.1 million had asthma and 15.1 million had COPD. The asthma/COPD therapeutics market is growing, with a high amount of momentum … |
View full post on asthma – Google News
 Stockopedia |
Sandoz Negotiates Expanded RoW Rights to Vectura's Asthma/COPD Drug VR315
Genetic Engineering News The Novartis generics business, Sandoz, negotiated expanded, rest-of-world (excluding the US) rights to Vectura's VR315 candidate combination therapy for asthma/COPD. Sandoz already holds European rights to the dry powder inhaler product. … Vectura Extends Novartis Deal For VR315 Lung Drug VECTURA GROUP PLC : VR315 RoW License Agreement Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello … |
View full post on asthma – Google News
|
Reportlinker Adds U.S. Asthma/COPD Market
PR Newswire (press release) This research service provides an in depth analysis of factors affecting the growth of the US asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, … |
View full post on asthma – Google News